The achievement of a 3-month complete cytogenetic response to second-generation tyrosine kinase inhibitors predicts survival in patients with chronic phase chronic myeloid leukemia after imatinib failure.
about
Combination of White Blood Cell Count at Presentation With Molecular Response at 3 Months Better Predicts Deep Molecular Responses to Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients.European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.Response-related predictors of survival in CML.Use of second- and third-generation tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia: an evolving treatment paradigm.Prognostic impact of persistent cytogenetic abnormalities at complete remission in adult patients with acute lymphoblastic leukemia.Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring.Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinib.Molecular responses at 3 and 6 months after switching to a second-generation tyrosine kinase inhibitor are complementary and predictive of long-term outcomes in patients with chronic myeloid leukemia who fail imatinib.
P2860
Q36478229-858FEDDA-9723-4938-93EC-2D0EE110ACC0Q37026032-5368EF3C-FF94-4EA4-BBD8-752498434353Q38392705-AA4BB7AB-1569-4C7E-B2FF-65FB19C23A3BQ38478174-117A09E2-B4B4-4FAE-B4A6-5909E75AFEFEQ40957292-E73DFA72-97E9-4453-9B26-B6C21D980EB3Q40957470-21851BF1-83E3-4F85-A6D5-BACBECEF7E94Q47824125-B44E569B-B2FE-479A-A201-A74BADDBEDAFQ54315749-089975B7-61B9-4C5E-8193-E89A4489276D
P2860
The achievement of a 3-month complete cytogenetic response to second-generation tyrosine kinase inhibitors predicts survival in patients with chronic phase chronic myeloid leukemia after imatinib failure.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The achievement of a 3-month c ...... ukemia after imatinib failure.
@ast
The achievement of a 3-month c ...... ukemia after imatinib failure.
@en
The achievement of a 3-month c ...... ukemia after imatinib failure.
@nl
type
label
The achievement of a 3-month c ...... ukemia after imatinib failure.
@ast
The achievement of a 3-month c ...... ukemia after imatinib failure.
@en
The achievement of a 3-month c ...... ukemia after imatinib failure.
@nl
prefLabel
The achievement of a 3-month c ...... ukemia after imatinib failure.
@ast
The achievement of a 3-month c ...... ukemia after imatinib failure.
@en
The achievement of a 3-month c ...... ukemia after imatinib failure.
@nl
P2860
P50
P1476
The achievement of a 3-month c ...... ukemia after imatinib failure.
@en
P2093
Hady Ghanem
Marylou Cardenas
P2860
P304
P356
10.1016/J.CLML.2012.12.005
P407
P50
P577
2013-01-12T00:00:00Z